healthcare
Bloomberg reporter Ryan Flinn recently wrote an article on Brain Scans Seek Best Drug Match for Depression Patients. The article summarizes some of the technologies that are being used by clinicians to assist in diagnosis and treatment of depression, and focused on technologies provided by two companies. The first company profiled uses a technology that matches […]
Read MoreJuly 11, 2012 source: MedCity News Ted was recently interview by MedCity News for two articles: Biggest threat to investment in mobile health startups? Not enough unique intellectual property VCs say a coachable entrepreneur, strong IP make convergence worth investing in Here are some excerpts from the interviews: Biggest threat to investment in mobile health […]
Read MoreI was struck recently by a piece in The Wall Street Journal by Pui-Wing Tam, The $1 Billion Club Gets Crowded, which highlights the amusing rate at which closely held, private US companies in the social media sector are garnering $1 billion-plus valuations. With 20 companies already fetching a 10-figure price tag— 15 of them since the beginning […]
Read More
March 7, 2012 source: Angel Capital Association (ACA) AssureRx Health, Inc. Receives 2012 ACA Luis Villalobos Award for Innovation Angel Capital Association Recognizes Company For Industry-leading Personalized Medicine Solution Hats off to one of my portfolio companies, AssureRx today received the the 2012 Luis Villalobos Award from the Angel Capital Association (ACA), the trade association of […]
Read More
January 18, 2012 source: MedCity News Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs. The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical […]
Read More
October 9, 2011 source: CBS News As part of CBS morning news, TIBION was profiled by correspondent Barry Peterson. At approximately four minutes 21 seconds into the video, see how TIBION stands out. We are proud of our portfolio company that is getting worldwide recognition. The next step in bionics … The new world of […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.